Smith J - Search Results

1

Prevention and treatment of experimental crescentic glomerulonephritis by blocking tumour necrosis factor-alpha.

Karkar AM, Smith J, Pusey CD. Karkar AM, et al. Among authors: smith j. Nephrol Dial Transplant. 2001 Mar;16(3):518-24. doi: 10.1093/ndt/16.3.518. Nephrol Dial Transplant. 2001. PMID: 11239025

2

Interleukin-11 attenuates nephrotoxic nephritis in Wistar Kyoto rats.

Lai PC, Cook HT, Smith J, Keith JC Jr, Pusey CD, Tam FW. Lai PC, et al. Among authors: smith j. J Am Soc Nephrol. 2001 Nov;12(11):2310-20. J Am Soc Nephrol. 2001. PMID: 11675407

3

CD28-B7 blockade prevents the development of experimental autoimmune glomerulonephritis.

Reynolds J, Tam FW, Chandraker A, Smith J, Karkar AM, Cross J, Peach R, Sayegh MH, Pusey CD. Reynolds J, et al. Among authors: smith j. J Clin Invest. 2000 Mar;105(5):643-51. doi: 10.1172/JCI6710. J Clin Invest. 2000. PMID: 10712436 Free PMC article.

4

Type IV phosphodiesterase inhibitor is effective in prevention and treatment of experimental crescentic glomerulonephritis.

Tam FW, Smith J, Agarwal S, Karkar AM, Morel D, Thompson EM, Pusey CD. Tam FW, et al. Among authors: smith j. Nephron. 2000 Jan;84(1):58-66. doi: 10.1159/000045539. Nephron. 2000. PMID: 10644909

5

Development of scarring and renal failure in a rat model of crescentic glomerulonephritis.

Tam FW, Smith J, Morel D, Karkar AM, Thompson EM, Cook HT, Pusey CD. Tam FW, et al. Among authors: smith j. Nephrol Dial Transplant. 1999 Jul;14(7):1658-66. doi: 10.1093/ndt/14.7.1658. Nephrol Dial Transplant. 1999. PMID: 10435873

6

Interleukin-4 ameliorates crescentic glomerulonephritis in Wistar Kyoto rats.

Cook HT, Singh SJ, Wembridge DE, Smith J, Tam FW, Pusey CD. Cook HT, et al. Among authors: smith j. Kidney Int. 1999 Apr;55(4):1319-26. doi: 10.1046/j.1523-1755.1999.00354.x. Kidney Int. 1999. PMID: 10200996

7

Differential expression of macrophage inflammatory protein-2 and monocyte chemoattractant protein-1 in experimental glomerulonephritis.

Tam FW, Karkar AM, Smith J, Yoshimura T, Steinkasserer A, Kurrle R, Langner K, Rees AJ. Tam FW, et al. Among authors: smith j. Kidney Int. 1996 Mar;49(3):715-21. doi: 10.1038/ki.1996.100. Kidney Int. 1996. PMID: 8648912

8

Glomerular expression of interleukin-1 receptor antagonist and interleukin-1 beta genes in antibody-mediated glomerulonephritis.

Tam FW, Smith J, Cashman SJ, Wang Y, Thompson EM, Rees AJ. Tam FW, et al. Among authors: smith j. Am J Pathol. 1994 Jul;145(1):126-36. Am J Pathol. 1994. PMID: 8030744 Free PMC article.

9

Prostaglandin E1 suppresses macrophage infiltration and ameliorates injury in an experimental model of macrophage-dependent glomerulonephritis.

Cattell V, Smith J, Cook HT. Cattell V, et al. Among authors: smith j. Clin Exp Immunol. 1990 Feb;79(2):260-5. doi: 10.1111/j.1365-2249.1990.tb05188.x. Clin Exp Immunol. 1990. PMID: 2311303 Free PMC article.

10

Interleukin-11 reduces renal injury and glomerular NF-kappa B activity in murine experimental glomerulonephritis.

Lai PC, Smith J, Bhangal G, Chaudhry KA, Chaudhry AN, Keith JC Jr, Tam FW, Pusey CD, Cook HT. Lai PC, et al. Among authors: smith j. Nephron Exp Nephrol. 2005;101(4):e146-54. doi: 10.1159/000087938. Epub 2005 Aug 30. Nephron Exp Nephrol. 2005. PMID: 16131809

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results